Organovo Holdings, Inc. - Common Stock (ONVO)

Organovo Holdings is a biotechnology company specializing in 3D bioprinting technologies with a focus on creating functional human tissues for medical research and therapeutic applications

By leveraging its innovative platform, the company aims to revolutionize the fields of drug discovery and regenerative medicine by enabling the generation of biologically relevant tissues that can be used for testing pharmaceutical compounds, understanding disease mechanisms, and potentially advancing personalized medicine solutions. Their work holds the promise of improving patient outcomes by providing more accurate models for studying human biology and disease.